Skip to main content

hong kong

近日,私募股权公司德福资本对港交所上市公司赛生药业提出私有化邀约。本次私有化交易通过协议安排方式实施,实施所需的现金总额约为 87.9 亿港元(约11.3 亿美元)。

高伟绅律师事务所为赛生药业提供法律服务;司力达律师事务所则为要约方财务顾问中金公司提供法律意见。

德福资本成立于 2010 年,是一家专注于中国医疗健康行业控股项目和成长期企业的投资公司。

赛生药业主要从事上市产品组合及其重点治疗领域(包括肿瘤及重症感染)在研产品开发与销售业务,其2021 3 月在港交所上市。

高伟绅团队由合伙人许文嘉和谭诗聪领导;

司力达团队的牵头合伙人为余嘉宝律师。

CC, Slaughter on SciClone’s $1.13 bln take-private deal in HK

Clifford Chance has advised SciClone Pharmaceuticals on its proposed take-private from HKEX by healthcare-focused private equity firm GL Capital, with Slaughter and May acting for the buyer’s financial adviser, Capital Corporation Hong Kong Securities (CICC).

The transaction was implemented via a scheme of arrangement, allowing for a cash consideration of up to approximately $1.13 billion.

Founded in 2010, GL Capital is an investment firm that focuses on buyouts and growth opportunities in China’s healthcare industry.

SciClone is engaged in developing and commercialising a portfolio of marketed products as well as pipeline with potential in its focused therapeutic areas, including oncology and severe infection. The company was listed in Hong Kong since March 2021.

The CC team was led by partners Christine Xu and Tommy Tam.

 The Slaughter team was headed by partner Bonita Yu.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

A&O Shearman、高赢助力中国生物医药公司普米斯9.5亿美元并购交易(ZH/EN)

近日,A&O Shearman作为BioNTech的法律顾问,为其收购中国生物医药公司普米斯提供法律服务;高赢国际律师事务所则为普米斯提供法律意见。

汉坤、方达、竞天公诚、凯易助力科创板首单“A收H”交易(ZH/EN)

科创板上市公司亚信安全完成香港联交所主板上市公司亚信科技的控制权收购。汉坤律师事务所在交易中为买方提供中国法律服务;方达律师事务所、凯易国际律师事务所则担任卖方法律顾问;竞天公诚律师事务所担任融资方渤海银行的法律顾问。

方达、苏利文、奋迅·贝克麦坚时助力中印26亿美元钢铁领域合资交易(ZH/EN)

中国民营钢铁公司中国东方集团宣布将与世界第二大钢铁公司、印度安赛乐米塔尔合作,共同在中国设立两家合营企业。方达律师事务所、美国苏利文·克伦威尔律师事务所作为中国东方集团的律师参与交易;奋迅·贝克麦坚时为安赛乐米塔尔提供法律意见。